A collaboration between Nvidia and startup Evozyne was able to produce novel versions of a human protein never before seen in nature but with enhanced function and the same safety as native protein. The research lays the groundwork for potential new therapies for a rare inherited disorder.
The Santa Clara, California company uses both machine learning and an advanced method of examining and managing network traffic, to secure connected devices and bring order in a world of IT chaos.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
SVB's healthcare investment report for 2019 found that Series A investment in platform technology exceeded oncology, which had led since 2013. The report forecast a 10-15% decrease in overall biopharma investment for 2020.
The chipmaker touted a new framework that would allow hospitals and pharmaceutical companies to collaborate on AI projects without sharing sensitive data. Nvidia said the framework is already gaining traction with hospitals and drug developers.
Silicon Valley Bank released its healthcare investments and exits trend report for the first half of 2019. It shows, among other things, oncology losing its first-place status in terms of Series A dollars raised.
A new partnership between Nvidia and the American College of Radiology will give a wider range of clinicians the ability to build, share and adapt their own AI models.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The Silicon Valley Bank parent company's shares were down 2 percent on the news that it would acquire the Boston-based investment bank.
Panelists at the Health 2.0 Provider Symposium pointed to the necessity of building aligned incentives to promote data sharing and drive innovation.
The company introduced its Clara platform, a combination of a new GPU-based hardware architecture and a software development kit allowing third-party developers to build applications for medical imaging.
Nvidia holds a dominant position in terms of making the chips that power artificial intelligence projects, but can the Silicon Valley tech company with roots in the world of gaming and graphics succeed in healthcare?
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Apple has launched a website indicating its interest in medical clinics to serve its employees under the name AC Wellness.
A new Frost and Sullivan report suggests that post-acute care facilities could strengthen their positions in an increasingly competitive landscape by integrating continuous monitoring technology and improving the outcome of high acuity patients.
At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.
Clinical data alone cannot transform healthcare as data from devices, sensors, social media and other sources need to be leveraged to enable behavior change and improve outcomes, says the former national coordinator of the ONC.
A look at some of the most interesting startups from Health 2.0's LAUNCH! event.